RecruitingPhase 2NCT05683886
A Study of KC1036 in Patients with Advanced Thymic Tumors
Studying Thymic tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Beijing Konruns Pharmaceutical Co., Ltd.
- Principal Investigator
- Yongsheng Wang, Ph.DWest China Hospital
- Intervention
- KC1036(drug)
- Enrollment
- 30 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2023 – 2026
Study locations (2)
- Shanghai Chest Hospital, Shanghai, Shanghai Municipality, China
- West China Hospital, Chengdu, Sichuan, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05683886 on ClinicalTrials.gov